SC 13G/A: UroGen Pharma Ltd.
Ticker: URGN · Form: SC 13G/A · Filed: 2024-05-08T00:00:00.000Z
Sentiment: neutral
Topics: sc-13g-a
AI Summary
SC 13G/A filing by UroGen Pharma Ltd..
Risk Assessment
Risk Level: low
From the Filing
EDGAR Filing Documents for 0001086364-24-007581 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home Company Search Current Page Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] SEC Accession No. 0001086364-24-007581 Filing Date 2024-05-08 Accepted 2024-05-08 14:22:56 Documents 1 Document Format Files Seq Description Document Type Size 1 il0011407140_050724.txt SC 13G/A 10688 Complete submission text file 0001086364-24-007581.txt 12465 Mailing Address 50 HUDSON YARDS NEW YORK NY 10001 Business Address 50 HUDSON YARDS NEW YORK NY 10001 212-810-5800 BlackRock Inc. (Filed by) CIK : 0001364742 (see all company filings) EIN. : 320174431 | State of Incorp.: DE | Fiscal Year End: 1231 Type: SC 13G/A SIC : 6211 Security Brokers, Dealers & Flotation Companies (CF Office: 02 Finance) Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601 UroGen Pharma Ltd. (Subject) CIK : 0001668243 (see all company filings) EIN. : 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231 Type: SC 13G/A | Act: 34 | File No.: 005-89992 | Film No.: 24925321 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)